CLINICAL USE
Antibacterial agent:Tuberculosis Staphylococcal infection
DOSE IN NORMAL RENAL FUNCTION
600–1200 mg daily in 2–4 divided doses
PHARMACOKINETICS
DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
ADMINISTRATION
Reconstition
Use solvent provided
Route
Oral, IV
Rate of Administration
2–3 hours
Comments
Dilute in 500 mL glucose 5% or sodium chloride 0.9%For central administration, 600 mg in 100 mL glucose 5% over 0.5–2 hours has been used (unlicensed). Stable for up to 24 hours at room temperature
OTHER INFORMATION
Some units give dose in concentrations up to 60 mg/mL (in its own solvent) over 10 minutes, on prescriber’s responsibilityMay cause acute interstitial nephritis, potassium wasting or renal tubular defectsReduce dose if LFTs are abnormal or patient <45 kgAbsorption from gastrointestinal tract can be reduced by up to 80% by the presence of food in the gastrointestinal tract
CAPD exit site infections: 300 mg twice daily for 4 weeks has been usedRifampicin is excreted into
CAPD fluid causing an orange/yellow colourMonitor rifampicin levels if necessary In severe renal impairment there is no increase in half-life at doses less than 600 mg daily.